Lataa...
Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations?
C-reactive protein (at values ≥50 mg/L) is a useful and cheap biomarker for making antibiotic decisions in patients hospitalised for an acute exacerbation of COPD with no additional risk of adverse effect or treatment failure #AECOPD http://bit.ly/342p0Nj
Tallennettuna:
| Julkaisussa: | Breathe (Sheff) |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
European Respiratory Society
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6885330/ https://ncbi.nlm.nih.gov/pubmed/31803274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/20734735.0257-2019 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|